Skip to main content
AAPL+0.64%MSFT+1.07%NVDA+0.64%GOOGL+0.80%AMZN+1.46%SPCX+1.27%TSM+0.81%AVGO+3.64%META+0.81%TSLA+0.74%LLY-2.33%WMT-0.13%AMD+5.31%SKHY-0.11%JPM-1.77%BRK-B-2.07%MU+1.55%V-0.37%JNJ-2.15%XOM-3.97%MA-0.37%ASMLa+1.94%ABBV-2.33%COST-1.21%1398.HK-0.66%0700.HK-6.20%KO-0.71%CVX-4.74%PG-0.83%CSCO+2.18%0939.HK-0.05%ORCL-0.97%3988.HK-0.44%GE+0.52%BAC-1.07%HD-0.40%1816.HK-26.65%0857.HK-1.46%UNH-10.21%1288.HK-1.42%PM-0.85%0005.HK-2.16%NVS-2.46%INTC-0.91%HSBA.L-2.00%MS-1.29%AMAT+0.88%AP2d+2.23%AZN-1.93%TXN-1.16%AUDJPY-1.68%AUDUSD-1.57%AUDCAD-1.00%EURAUD+0.99%AUDCHF-0.98%GBPAUD+0.91%AUDNZD-0.87%NZDJPY-0.83%GBPJPY-0.78%EURJPY-0.73%CHFJPY-0.70%CADJPY-0.70%NZDUSD-0.70%GBPUSD-0.65%USDCHF+0.62%AUDSGD-0.62%EURUSD-0.60%USDCAD+0.59%AUDDKK-0.54%USDZAR+0.47%USDMXN+0.42%GBPTRY+0.41%USDTHB+0.39%AUDNOK-0.37%USDNOK+0.33%GBPHKD+0.32%EURZAR+0.31%NZDMXN+0.30%GBPMXN-0.28%GBPZAR+0.28%CHFNOK+0.26%NOKJPY-0.25%USDSEK+0.24%USDPLN+0.21%USDTRY+0.21%EURCNH-0.19%EURNOK+0.19%EURHKD-0.17%CHFSEK+0.16%USDILS+0.16%USDDKK+0.16%USDJPY-0.14%NZDCAD-0.13%PLNJPY-0.12%USDCNH-0.12%GBPSGD-0.11%NZDCHF-0.11%EURNZD+0.10%EURSGD-0.08%EURSEK+0.08%GBPCAD-0.08%USDSGD+0.07%EURGBP+0.06%GBPNZD+0.05%EURPLN+0.05%EURCZK+0.04%USDCOP-0.04%GBPCHF-0.03%CADCHF+0.03%EURCHF+0.02%SGDJPY+0.02%USDHKD-0.02%NZDSGD-0.02%EURCAD-0.01%CHFSGD0.00%EURDKK0.00%XPTUSD-1.21%XAGUSD-0.81%GAGUSD-0.81%W1-0.62%HG1-0.60%XAUUSD-0.51%GAUUSD-0.51%C1-0.46%XNGUSD-0.38%S1-0.25%UKOIL+0.16%USOIL-0.10%BTCUSD-3.54%ETHUSD+57.77%USDTUSD-0.01%XRPUSD+52.58%SOLUSD+57.55%TRXUSDT+0.74%ZECUSDT-6.89%XMRUSDT-2.10%DOGEUSD+55.95%LINKUSD-3.33%XLMUSD-3.84%BCHUSDT-3.55%LTCUSD+47.50%UNIUSD-3.16%SUIUSD-2.99%TONUSD+59.18%HBARUSDT-5.19%TAOUSDT-3.19%AAVEUSD-3.38%ONDOUSDT-5.32%ICPUSDT-2.18%DOTUSDT-3.76%WLDUSDT-3.57%ARBUSDT-5.60%ATOMUSDT-2.39%INJUSDT-7.45%STXUSDT-3.46%PYTHUSDT-0.81%TIAUSDT-3.10%FETUSDT-4.61%JUPUSDT+0.25%SEIUSDT-4.48%GRTUSDT-3.22%OPUSDT-3.90%IOTAUSDT-2.52%POLUSDT-2.08%WIFUSDT-2.98%AXSUSDT-3.05%EOSUSDT-4.31%IMXUSDT-3.36%FARTCOINUSDT-6.94%GALAUSDT-2.38%DYDXUSDT-2.85%ORDIUSDT-2.64%NOTUSDT-2.34%RONINUSDT-2.92%AAPL+0.64%MSFT+1.07%NVDA+0.64%GOOGL+0.80%AMZN+1.46%SPCX+1.27%TSM+0.81%AVGO+3.64%META+0.81%TSLA+0.74%LLY-2.33%WMT-0.13%AMD+5.31%SKHY-0.11%JPM-1.77%BRK-B-2.07%MU+1.55%V-0.37%JNJ-2.15%XOM-3.97%MA-0.37%ASMLa+1.94%ABBV-2.33%COST-1.21%1398.HK-0.66%0700.HK-6.20%KO-0.71%CVX-4.74%PG-0.83%CSCO+2.18%0939.HK-0.05%ORCL-0.97%3988.HK-0.44%GE+0.52%BAC-1.07%HD-0.40%1816.HK-26.65%0857.HK-1.46%UNH-10.21%1288.HK-1.42%PM-0.85%0005.HK-2.16%NVS-2.46%INTC-0.91%HSBA.L-2.00%MS-1.29%AMAT+0.88%AP2d+2.23%AZN-1.93%TXN-1.16%AUDJPY-1.68%AUDUSD-1.57%AUDCAD-1.00%EURAUD+0.99%AUDCHF-0.98%GBPAUD+0.91%AUDNZD-0.87%NZDJPY-0.83%GBPJPY-0.78%EURJPY-0.73%CHFJPY-0.70%CADJPY-0.70%NZDUSD-0.70%GBPUSD-0.65%USDCHF+0.62%AUDSGD-0.62%EURUSD-0.60%USDCAD+0.59%AUDDKK-0.54%USDZAR+0.47%USDMXN+0.42%GBPTRY+0.41%USDTHB+0.39%AUDNOK-0.37%USDNOK+0.33%GBPHKD+0.32%EURZAR+0.31%NZDMXN+0.30%GBPMXN-0.28%GBPZAR+0.28%CHFNOK+0.26%NOKJPY-0.25%USDSEK+0.24%USDPLN+0.21%USDTRY+0.21%EURCNH-0.19%EURNOK+0.19%EURHKD-0.17%CHFSEK+0.16%USDILS+0.16%USDDKK+0.16%USDJPY-0.14%NZDCAD-0.13%PLNJPY-0.12%USDCNH-0.12%GBPSGD-0.11%NZDCHF-0.11%EURNZD+0.10%EURSGD-0.08%EURSEK+0.08%GBPCAD-0.08%USDSGD+0.07%EURGBP+0.06%GBPNZD+0.05%EURPLN+0.05%EURCZK+0.04%USDCOP-0.04%GBPCHF-0.03%CADCHF+0.03%EURCHF+0.02%SGDJPY+0.02%USDHKD-0.02%NZDSGD-0.02%EURCAD-0.01%CHFSGD0.00%EURDKK0.00%XPTUSD-1.21%XAGUSD-0.81%GAGUSD-0.81%W1-0.62%HG1-0.60%XAUUSD-0.51%GAUUSD-0.51%C1-0.46%XNGUSD-0.38%S1-0.25%UKOIL+0.16%USOIL-0.10%BTCUSD-3.54%ETHUSD+57.77%USDTUSD-0.01%XRPUSD+52.58%SOLUSD+57.55%TRXUSDT+0.74%ZECUSDT-6.89%XMRUSDT-2.10%DOGEUSD+55.95%LINKUSD-3.33%XLMUSD-3.84%BCHUSDT-3.55%LTCUSD+47.50%UNIUSD-3.16%SUIUSD-2.99%TONUSD+59.18%HBARUSDT-5.19%TAOUSDT-3.19%AAVEUSD-3.38%ONDOUSDT-5.32%ICPUSDT-2.18%DOTUSDT-3.76%WLDUSDT-3.57%ARBUSDT-5.60%ATOMUSDT-2.39%INJUSDT-7.45%STXUSDT-3.46%PYTHUSDT-0.81%TIAUSDT-3.10%FETUSDT-4.61%JUPUSDT+0.25%SEIUSDT-4.48%GRTUSDT-3.22%OPUSDT-3.90%IOTAUSDT-2.52%POLUSDT-2.08%WIFUSDT-2.98%AXSUSDT-3.05%EOSUSDT-4.31%IMXUSDT-3.36%FARTCOINUSDT-6.94%GALAUSDT-2.38%DYDXUSDT-2.85%ORDIUSDT-2.64%NOTUSDT-2.34%RONINUSDT-2.92%
CT

Corcept Therapeutics Incorporated (CORT)

NASDAQ • Healthcare

$67.79
-$2.27 (-3.3%)
Market closed

Last close at November 18, 2026 at 21:00 UTC

Open$71.01
Day Range$67.24 - $71.5
Avg. Volume (3M)1.3M
Market Cap$7.4B
P/E Ratio45.2
52 Week Range
$28.66$126.38

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$340.4M100%
Gross Profitminus cost of goods$335.8M99%
Operating Incomeminus R&D and overhead$114.7M34%
Net Incomeminus taxes and the rest$126.7M37%

In plain terms: out of every $100 in revenue, Corcept Therapeutics Incorporated keeps $37 as net profit.

Fundamentals & Financials

Revenue (TTM)
$963.6M
Net Income (TTM)
$162M
EPS (TTM)
$1.5
ROA (TTM)
15.67%
Current Ratio
3

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-172.3%Q2 2026-$0.3
+1383.3%Q3 2026$0.36
+20.2%Q4 2026$1.01

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +20.2%

Corcept Therapeutics’ revenue topped consensus in the third fiscal quarter of 2026, with results reported November 3, 2026, as revenue rose 64% to about $340.5 million, up from $207.6 million a year ago, and came in at $340.5 million versus a $336.4 million estimate (+1.2%, topped). The quarter’s sales were driven by Korlym, the company’s cortisol modulation product in the U.S. commercial business. Profitability stayed high, with gross profit of roughly $335.9 million translating to a gross margin of ~99%, and the company generated operating cash flow of about $142.9 million. On the forward view, next-period consensus calls for EPS of $1.13 on revenue of $388.7 million.

View full earnings history

About Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated (NASDAQ: CORT) is a U.S. pharmaceutical company focused on cortisol modulation. Its business today centers on Korlym, an oral medication taken once daily, and it generated $761.4 million of revenue in FY2025 from operations in the healthcare sector.

Name
Corcept Therapeutics Incorporated
CEO
Joseph K. Belanoff
Industry
Healthcare
Year Founded
1998
Employees
730

Today's Snapshot

AI-generated

The day ended with CORT 3.2% lower at 67.79, in line with a weaker sector. Volume was about two-thirds of its usual level.

Trading Volume

Below 10d avg (1.2M)

744.8K

vs S&P 500 Today

Underperforming Market

-2.99%

Updated: November 18, 2026 at 21:28 UTC

Technical Indicators

2 Buy0 Neutral6 Sell
CORT displays pronounced technical deterioration: ADX is very strong, indicating a dominant trend, and momentum measures including MACD and short momentum are deeply negative while RSI and stochastic are oversold. The price is well below short-, medium- and long-term moving averages and the classic pivot sits above the current level, reinforcing resistance. Volatility is elevated by ATR, and OBV shows net selling, so volume confirms the downside bias. Technical takeaway: Strong Sell — strong trend, heavy selling volume and moving averages aligned to the downside.
All signals
  • EMA (5 indicators)$73.36 - $94.24
    Sell
  • RSI (14)23.67
    Buy
  • Stochastic %K (14, 3, 3)6.17
    Buy
  • MACD Level (12, 26)-9.69
    Sell

Peers & Related Assets

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.